1.A clinical study of splenectomy.
Choon Gon SHIN ; Jin Hyun PARK ; Byung Chul LEE
Journal of the Korean Surgical Society 1991;41(1):93-99
No abstract available.
Splenectomy*
2.Splenectomy in hematologic disorders.
Hee Dong BAE ; Jee Sook HAHN ; Sun Ju LEE ; Si Chan KIM ; Yoo Hong MIN ; Yun Woong KO
Korean Journal of Hematology 1992;27(2):301-308
No abstract available.
Splenectomy*
3.Late but effective long-term response to splenectomy in the treatment of immune thrombocytopenia.
Laura SCARAMUCCI ; Marco GIOVANNINI ; Andrea TENDAS ; Pasquale NISCOLA ; Paolo DE FABRITIIS
Blood Research 2013;48(4):297-298
No abstract available.
Splenectomy*
;
Thrombocytopenia*
4.Splenomegaly and Splenectomy.
Korean Journal of Pediatrics 2004;47(Suppl 2):S277-S281
No abstract available.
Splenectomy*
;
Splenomegaly*
5.Some opinion of emergency splenectomy
Journal of Vietnamese Medicine 2001;263(9):28-32
Emergency splenectomy is the therapy of choice after trying to prevent bleeding by other methods. Without result in immune thrombocytopenic for operative in patient to reduce mortality and morbidity rate. It is now generally agreed that splenectomy is not only a valid alternative to medical treatment but is associated with a significantly higher rate of permanent remission.
Splenectomy
;
Emergencies
6.Splenectomy in children
Journal of Medical and Pharmaceutical Information 2000;(4):4-7
Spleen plays important functions in the body. There were many indications for splenectomy, including spleen traumas, splenorenal shunt, vascular accident due to the spleen, splenic cyst, splenomegaly compressing other organs, congenital hemolytic anemia, acquired immunohematological diseases, hypersplenism leading to the peripheral blood cell deficiency. The major risk after splenectomy was severe infection. The hypersplenism was improved after splenectomy.
Splenectomy
;
Child
7.Learning indications for splenectomy
Journal of Practical Medicine 2002;435(11):36-40
Some major conditions that related to indication of splenectomy are 1. Rupture; 2. Abscess; 3. Tumors and cysts; 4. Artery aneurysm; 5. Displacement of spleen; 6. Bone marrow failure; 7. Faconi’s anemia; 8. Diamond-Blackfan’s anemia; 9. Gaucher’s disease; 10. Hemolytic anemia; 11. Essential trombocytopenia hemorrhage. 12. Felty syndrome; 13. Essential myelodysplasia; 14. Hairy leucocyte disease; 15. Hodgkin disease. Indications included splenectomy for diagnosis and for treatment and splenectomy for cases of spleen enlargement with spleen hyperactivity syndrome.
Splenectomy
;
Learning
8.Laparoscopic splenectomy for sclerosing angiomatoid nodular transformation of the spleen.
Ki Han KIM ; Seul LEE ; Soon Hwa YOUN ; Mi Ri LEE ; Min Chan KIM ; Seo Hee RHA ; Ghap Joong JUNG
Journal of the Korean Surgical Society 2011;80(Suppl 1):S59-S62
Primary splenic tumors are rare and mainly found incidentally on radiologic studies. Among them, sclerosing angiomatoid nodular transformation (SANT) of the spleen is a new entity defined as a benign pathologic lesion. Most SANTs have no clinical symptoms and are occasionally accompanied by other splenic diseases such as malignancies. So, the exact diagnosis of the nature of the splenic tumor is mandatory for further treatment. But, preoperative diagnosis is not easy since it is difficult to obtain the tissue from the spleen for pathological study. Recently, laparoscopic splenectomy has become the more standard procedure for the spleen for diagnosis and treatment. Here, we report a rare case of SANT diagnosed following laparoscopic splenectomy.
Spleen
;
Splenectomy
;
Splenic Diseases
9.A study on the change of the lymphocyte subsets after splenectomy by flow cytometer.
Hoi Sang JEONG ; Baik Hwan CHO ; Yong HWANG
Journal of the Korean Surgical Society 1992;43(4):574-584
No abstract available.
Lymphocyte Subsets*
;
Lymphocytes*
;
Splenectomy*
10.Evaluation of the effects of splenectomy in treating chronic immuno thrombocytopenic purpurea
Journal of Vietnamese Medicine 2004;299(6):13-22
From Aug-2000 to Aug-2003 at HCM City Blood Transfusion and Hematology hospital, 31 cases of endoscopic splenectomy were studied to evaluate the effect of this surgery to treat chronical immuno-thrombocytopenic purpurea once corticotherapy and immunosupressive therapy failed. Results showed that one year after splenectomy, 64,52 – 76,92%, and 2 years after, 50% of cases had had completely positive response. There was absolute failure in 38,7% of cases within 3 first months, but from the 4th month, there was no relapse case. A half number of patients with failed splenectomy had had quick response to corticotherapy more.The duration of treatment was short, endoscopic splenectomy was safe. There was no death. No case of blood transfusion was needed. There were no complications
Splenectomy
;
Therapeutics
;
Purpura, Thrombocytopenic